Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ACEA Biosciences logo — Evelopment and commercialization of high performance cell an...

ACEA Biosciences

Evelopment and commercialization of high performance cell analysis platforms for life science research

Founded 2002 United States San Diego, United States 55 employees Total: $321.00M Analytics, Biotechnology +1

General Information

Company Name ACEA Biosciences
Founded Year 2002
Location United States San Diego, United States
Employees 55
Industries Analytics, Biotechnology, Autonomous and Sensor Tech
Social

BounceWatch is an independent company data service, not affiliated with ACEA Biosciences. To contact ACEA Biosciences, visit aceabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ACEA Biosciences compare?

A PDF of ACEA Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ACEA Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ACEA Biosciences

ACEA Biosciences, now part of Agilent Technologies, stands at the forefront of the biotech industry with its high-performance cell analysis platforms. Since its founding in 2002, this United States-based company has innovatively contributed to Analytics, Biotechnology, and Autonomous and Sensor Tech sectors.

With pivotal products like the xCELLigence® Real-Time Cell Analysis instruments and NovoCyte® aQuanteon flow cytometers, ACEA Biosciences serves critical applications in pre-clinical drug discovery, toxicology, and academic research. The global impact is evident with over 2,500 instruments deployed worldwide, supporting more than 1,800 peer-reviewed publications.

Most recently, in 2019, they received a $20.00M Late VC investment from Qiming Venture Partners, underscoring strong investor confidence. ACEA Biosciences continues to advance life science research with its commitment to cutting-edge cell analysis technology.

Business keywords: Cell Analysis Platforms, Real-Time Cell Analysis, Flow Cytometry, Preclinical Drug Discovery, Toxicology, Safety Pharmacology, Oncology Drug Discovery, Biosensor Technology, Cell-Based Assays, Cardiotoxicity Research, Immunotherapy, Cancer Research, Drug Screening, Infectious Disease Research, Stem Cell Research

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC $20.00M 1
Qiming Venture Partners
Qiming Venture Partners
01 Mar 2019
Acquisition $250.00M 1
Agilent
01 Sep 2018
Series E $15.00M 1
Qiming Venture Partners
Qiming Venture Partners
01 Mar 2018
Series E $6.00M -
01 Apr 2016
Early VC $30.00M 1
Lilly Asia Ventures
Lilly Asia Ventures
01 Nov 2015

ACEA Biosciences Alternatives & Competitors

ACEA Biosciences vs
Cyntellect
Cyntellect

Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing tech...

Series E
9 employees
Analytics, Biotechnology
ACEA Biosciences vs
Invivo Biosciences
Invivo Biosciences India

A Contract Research Organization with Services provided across the Value Chain

14 employees
Analytics, Biopharma

FAQ About ACEA Biosciences

Evelopment and commercialization of high performance cell analysis platforms for life science research
ACEA Biosciences was founded in 2002.
ACEA Biosciences is headquartered in San Diego, United States.
ACEA Biosciences operates in Analytics, Biotechnology and Autonomous and Sensor Tech. Its work centres on Cell Analysis Platforms, Real-Time Cell Analysis, Flow Cytometry and Preclinical Drug Discovery.
ACEA Biosciences has approximately 55 employees.
ACEA Biosciences has completed 5 funding rounds, raising a total of $321.00M.
Top alternatives and competitors to ACEA Biosciences include Cyntellect, Invivo Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ACEA Biosciences and Cyntellect are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ACEA Biosciences, https://bouncewatch.com/company/acea-biosciences, updated 2 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout